• Doctors Cancer Foundation, Inc, 2006-2099, The Role of GSK3B in Carcinoid and other Neuroendocrine Cancers 
• University of Wisconsin-Madison, 2007-2034, Valproic Acid - Thyroid Cancer
• NIH, 2009-2014, GSK3-Beta Signaling in Medullary Thyroid Cancer
• NIH, 2011-2013, Surgery Summer Research Experience for Medical Students
• American Cancer Society, Inc, 2010-2015, Establishment of an MEN2 Thyroid Cancer Research and Training Program
• Saudi Arabian Cultural Mission, 2009-2014, Memorandum of Understanding between the Saudi Cultural Mission and the Board of the University of Wisconsin Systems to Establish a Surgical Fellowship
• NIH, 2011-2016, Surgical Oncology Research Training Program
• NIH, 2011-2013, AAS Courses to Increase Women and Minorities in Academic Surgery
• American College of Surgeons, 2011-2013, Targeting Notch in Medullary Thyroid Cancer Fellowship for Jocelyn Burke
• American Cancer Society, Inc, 2011-2016, Notch Signaling in Medullary Thyroid Cancer
• Novo Nordisk Pharmaceuticals, Inc, 2011-2026, Medullary Thyroid Carcinoma Surveillance Study: a Case Series Registry
• UWF- University of Wisconsin Foundation, 2012-2014, Surgery Clinical Research Experiences for High School Students

• 8,338,482 - Modulating notch1 signaling pathway for treating neuroendocrine tumors, granted Dec 2012.

• "REMNANT UPTAKE AS A POSTOPERATIVE ONCOLOGIC QUALITY INDICATOR"

Schneider DF, Ojomo KA, Chen H, et al., Thyroid: official journal of the American Thyroid Association Feb 2013. The purpose of this study was to examine the utility of remnant uptake on postoperative radioiodine scans as an oncologic indicator after thyroidectomy for differentiated thyroid cancer (DTC). Pubmed/NLM.

• ""Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary hyperparathyroidism"

Burke JF, Naraharisetty K, Schneider DF, et al., American Journal of Surgery Jan 2013. A review of early scans in patients with negative imaging increases accurate adenoma localization and allows for minimally invasive operations in more patients. Pubmed/NLM.

• "Lymph Node Ratio Predicts Recurrence in Papillary Thyroid Cancer"

Schneider DF, Mazeh H, Chen H, et al., The Oncologist Jan 2013. Lymph node metastasis occurs in 20%-50% of patients presenting for initial treatment of papillary thyroid cancer (PTC). The significance of lymph node metastases remains controversial, and the aim of this study is to determine how the lymph node ratio (LNR) may predict the likelihood of disease recurrence. Pubmed/NLM.

• "Using Body Mass Index to Predict Optimal Thyroid Dosing after Thyroidectomy"
  

Ojomo KA, Schneider DF, Reiher AE, et al., Journal of the American  College of Surgeons Jan 2013. The current standard of weight-based thyroid replacement fails to appropriately dose underweight and overweight patients. Body mass index can be used to more accurately dose thyroid hormone using a simple formula. Pubmed/NLM.